Correlation between oral sex and a low incidence of preeclampsia: A role for soluble HLA in seminal fluid?

Journal of Reproductive Immunology

Volumn 46, Issue 2, 2000, Pages

  Koelman, Carin A ^a   Coumans, Audrey B C ^b   Nijman, Hans W ^b   Doxiadis, Ilias I N ^a   Dekker, Gustaaf A ^b   Claas, Frans H J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Oral sex; Preeclampsia; sHLA I; Soluble HLA; Sperm; Tolerance

Indexed keywords

HLA A2 ANTIGEN; HLA A9 ANTIGEN; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA B51 ANTIGEN; HLA B7 ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; MALE; PREECLAMPSIA; PRIORITY JOURNAL; SEMINAL PLASMA; SEXUAL BEHAVIOR;

DEGLUTITION; FEMALE; HLA ANTIGENS; HUMANS; IMMUNE TOLERANCE; INCIDENCE; MALE; MOUTH MUCOSA; PRE-ECLAMPSIA; PREGNANCY; QUESTIONNAIRES; SEMEN; SEXUAL BEHAVIOR;

EID: 0342905388     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0378(99)00062-5     Document Type: Article

References (39)

1. Astin M., Scott J.R., Worley R.J. Pre-eclampsia/eclampsia: the fatal father factor. Lancet. II:1981;533.
2. Brandtzaeg P. History of oral tolerance and mucosal immunity. Ann. NY Acad. Sci. 13:1996;1-27.
3. Buelow R., Burlingham W.J., Clayberger C. Immunomodulation by soluble HLA class I. Transplantation. 59(5):1995;649-654.
4. Burlingham W.J., Grailer A.P., Heisey D.M., Claas F.H.J., Norman D., Mohanakumar T. et al. The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors. New Engl. J. Med. 339:1998;1657-1664.
5. Campbell D.A., Lorber M.I., Seeton J.C., Turcotte J.G., Niederhuber J.G., Beer A.E. Breast feeding and maternal-donor renal allografts. Transplantation. 37:1984;340-344.
6. Campbell D. Pre-eclampsia in second pregnancy. Br. J. Obstet. Gynaecol. 92:1985;131-135.
7. Castilla J.A., Gil T., Rodriguez F., Molina J., Samaniego F., Vergara F., Herruzo A.J. Lack of expression of HLA antigens on immature germ cells form ejaculates with antisperm antibodies. Castilla J. A. 30:1993;9-14.
8. Chng P.K. Occurrence of preeclampsia in pregnancies to three husbands: case report. Br. J. Obstet. Gynaec. 89:1982;862-863.
9. Darke C., Dyer P. Clinical typing by cytotoxicity. Dyer P., Middleton D. Histocompatibility Testing, A Practical Approach. 1993;51-80 Oxford University Press, Oxford.
10. Dekker G.A., Tubbergen P., Valk M., Althuisius S.M., Lachmeijer A.M.A. Change in paternity: a risk factor for preeclampsia in multiparous women. Am. J. Obstet. Gynecol. 178:1998;S120.
11. Doxiadis I., Westhoff U., Grosse-Wilde H. Quantification of soluble HLA class I gene products by an enzyme linked immunosorbent assay. Blut. 59:1989;449-454.
12. Feeney J.G. Influence of previous blood transfusion of incidence of pre-eclampsia. Lancet. i:1977;874-875.
13. Feeney J.G. Pre-eclampsia and changed paternity. Eur. J. Obstet. Gynecol. Reprod. Biol. 11:1980;35-38.
14. Ikedife D. Eclampsia in multipara. Br. Med. J. 280:1980;985-986.
15. Klonoff-Cohen H.S. An epidemiologic study of contraception and pre-eclampsia. J. Am. Med. Assoc. 262:1987;3143-3146.
16. Koelman C.A., Mulder A., Jutte N.H.P.M., Vaessen L.M.B., Balk A., Weimar W. et al. The application of human monoclonal antibodies for monitoring donor derived soluble HLA class I molecules in the serum of heart transplant recipients. Hum. Immunol. 59:1998;106-114.
17. Koelman C.A., Ensink W., Mulder A., Tanke J., Doxiadis I.I.N., Claas F.H.J. Anti-HLA antibodies interfere in the detection of soluble HLA class I molecules. Hum. Immunol. 60:1999;414-423.
18. Krensky A.M., Clayberger C. The induction of tolerance to alloantigens using HLA-based synthetic peptides. Curr. Opin. Immunol. 6:1994;791-796.
19. Liem L.M., Koelman C.A., Doxiadis I.I.N., Houwelingen J.C., Goulmy E., Claas F.H.J. Elevated serum HLA class I levels coincide with acute and chronic graft-versus-host disease. Bone Marrow Transpl. 20:1997;227-234.
20. Marti J., Herrmann U. Immunogestosis: a new etiologic concept of essential EPH gestosis, with special consideration of the primigravid patient. Am. J. Obstet. Gynaecol. 128:1977;489-491.
21. Mowbray J.F. Controlled trial of treatment of recurrent spontaneous abortion by immunization with paternal cells. Lancet. 17:1988;297-302.
22. Mulder A., Kardol M.J., Niterink J.G.S., Parlevliet J.H., Marrari M., Tanke J. et al. Succesful strategy for the large scale development of HLA-human monoclonal antibodies. Charron D. Genetic Diversity of HLA: Functional and Medical Implications. 1997;354-356 EDK Publishers, Sevres.
23. Naipal A., D'Amaro J., Bruning J.W., van Leeuwen A., van Rood J.J. Automated reading of propidium iodide lymphocytotxicity tests for HLA-DR, MB, and MT typing. Tissue Antig. 24:1984;302.
24. Opelz G., Sengar D.P.S., Mickey M.R., Terasaki P.I. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc. 5:1973;253.
25. Pouletty P., Ferrone S., Amesland F., Cohen N., Westhoff U., Charron D. et al. Summary report from the first international workshop on soluble HLA antigens. Paris, August 1992. Tissue Antig. 42:1993;45-54.
26. Regan L., Braude P.R., Hill D.P. A prospective study of the incidence, time of appearance and significance of anti-paternal lymphocytotoxic antibodies in human pregnancy. Hum. Reprod. 6:1991;294-298.
27. Robillard P.Y. Association of pregnancy-induced hypertension with duration of sexual cohabitation before conception. Lancet. 344:1994;973-975.
28. Robillard P.Y., Hulsey T.C., Alexander G.R., Keenan A., de Caunes F., Papiernik E. Paternity patterns and risk of preeclampsia in the last pregnancy in multiparae. J. Reprod. Immunol. 24:1993;1-12.
29. Sacks G.P., Studena K.M.D., Sargent I.L., Redman C.W.G. Normal pregnancy and preeclampsia both produce inflammatory changes in blood leukocytes akin to those of sepsis. Am. J. Obstet. Gynecol. 179:1998;80-86.
30. Sayegh M.H., Khoury S.J., Hancock W.W., Weiner H.L., Carpenter C.B. Mechanisms of oral tolerance by MHC peptides. Ann. NY Acad. Sci. 13:1996;338-345.
31. Schaller J., Glander H.J., Ladusch M., Westhoff U., Grosse-Wilde H. Lack of HLA-molecules on human spermatozoa and in seminal plasma. Andrologia. 25:1993;77-81.
32. Serhal P.F., Craft I. Immune basis for pre-eclampsia: evidence from oocyte recipients. Lancet. i:1987;744-746.
33. Serhal P.F., Craft I.L. Oocyte donation in 61 patients. Lancet. I:1989;1185-1187.
34. Sosroseno W. A review of the mechanisms of oral tolerance and immunotherapy. J. F. Soc. Med. 88:1995;14-17.
35. Strickland D.M. The relationship between abortion in the first pregnancy and development of pregnancy-induced hypertension in the subsequent pregnancy. Am. J. Obstet. Gynecol. 154:1986;146-148.
36. Taylor C., Faulk P.W. Prevention of recurrent abortion with leucocyte transfusions. Lancet. II:1981;68-69.
37. Vinatier D., Monnier J.C. Preeclampsia: physiology and immunological aspects. Eur. J. Obstet. Gynecol. Reprod. Biol. 61:1995;85-97.
38. Yang L., DuTemple B., Gorczynski R.M., Levy G., Zhang L. Evidence for epitope spreading and active suppression in skin graft tolerance after donor-specific transfusion. Transplantation. 67:1999;1404-1410.
39. Zavazava N., Kronke M. sHLA class I molecules induce apoptosis in alloreactive cytotoxic T cells. Nat. Med. 2:1996;1005-1011.